|
evaluation research
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
PAR-25-025 · National Institutes of Health
|
biomedical clinical
public health
ai data science
|
$1,515,000 |
2024-12-05 |
2027-02-03 |
90 |
|
evaluation research
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
PAR-25-026 · National Institutes of Health
|
biomedical clinical
public health
|
— |
2024-12-05 |
2027-02-03 |
90 |
|
evaluation research
|
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
RFA-CA-28-013 · National Institutes of Health
|
biomedical clinical
public health
environment
|
$700,000 |
2026-10-09 |
2027-02-09 |
96 |